ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

WuXi Builds Up Biologics Research

by Jean-François Tremblay
January 18, 2016 | APPEARED IN VOLUME 94, ISSUE 3

WuXi AppTec is spending $120 million on a biologics research center at its Shanghai headquarters. Expected to open in 2017, the center will employ up to 800 scientists. It will aim to support companies and research groups worldwide that are working on new monoclonal antibodies and antibody-drug conjugates. Also able to manufacture biologics, the facility will be equipped with bioreactors with capacities of up to 2,000 L.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment